RTX Q3 2024/25 slides: revenue growth and margin expansion lead to raised guidance

RTX A/S reported robust Q3 2024/25 results, with nine-month revenue increasing 16.7% year-over-year to 407 million DKK and significant profitability improvements, including a gross margin expansion to 51.7% and a positive nine-month EBITDA of 22.2 million DKK, up from a prior-year loss. This strong performance, primarily driven by growth in its Enterprise and Healthcare segments, led the company to raise its full-year 2024/25 revenue and EBITDA guidance and announce a new 20 million DKK share buyback program, signaling increased financial strength and management confidence.

Analysis

RTX A/S (CPH:RTX) reported a strong third quarter for fiscal year 2024/25, characterized by a significant turnaround in profitability and improved financial health, prompting an upward revision of its full-year guidance. While quarterly revenue saw a modest increase to 147 million DKK, nine-month revenue grew a robust 16.7% year-over-year to 407 million DKK. The core of the positive results lies in margin expansion; the nine-month gross margin improved to 50.7% from 44.9% a year prior, attributed to a favorable product mix and cost optimizations. This fueled a dramatic swing in nine-month EBITDA to a profit of 22.2 million DKK from a loss of 20.1 million DKK in the prior-year period. Performance was driven by the Enterprise segment, which grew 31% over nine months, and the Healthcare segment, where Q3 revenue nearly doubled. This strength offset pronounced weakness in the ProAudio segment, where nine-month revenue declined from 92 million to 56 million DKK due to lower volumes from key customers. The company's balance sheet and cash flow have also strengthened, with inventory levels falling to 56.5 million DKK from 90.7 million DKK and nine-month free cash flow turning positive at 11.6 million DKK. The announcement of a new 20 million DKK share buyback program underscores management's confidence and commitment to shareholder returns.

Key Decisions for Investors

• The significant improvement in profitability, particularly the EBITDA turnaround from a substantial loss to a profit, suggests the company's strategic focus on higher-margin segments is successfully executing, warranting a constructive outlook on the stock.
• Investors should closely monitor the diverging performance of the business segments, as continued strength in Enterprise and Healthcare must be weighed against the persistent weakness in ProAudio, which remains a drag on overall growth.
• The new 20 million DKK share buyback program provides a clear catalyst for EPS accretion and signals management's view of an attractive valuation, while the improved free cash flow and reduced inventory demonstrate enhanced operational efficiency.
• While the raised full-year guidance is a strong positive signal, the noted visibility of only 3-6 months on the order book introduces a degree of uncertainty that requires monitoring in subsequent quarters.